Generating novel predictive models to estimate the risk of future ASCVD & Dementia in older adults

生成新的预测模型来估计未来 ASCVD 的风险

基本信息

  • 批准号:
    10474464
  • 负责人:
  • 金额:
    $ 16.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Response to Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) Competition Title: Generating novel predictive models to estimate the risk of future ASCVD & Dementia in older adults Project Summary/Abstract: A person’s baseline risk determines to a large extent their anticipated benefit from many preventive treatments. Older patients desire to live longer while maintaining cognitive function and freedom from dementia, including Alzheimer’s disease, the #1 cause of morbidity and disability in older adults. Older adults also prioritize avoiding atherosclerotic cardiovascular disease (ASCVD), the #1 killer of older adults. Importantly, many risk factors for Alzheimer’s disease and dementia also increase risk for ASCVD. Alzheimer’s disease is the most common etiologic basis for incident mild cognitive impairment and dementia in older adults and can be identified as the cause in 70-75% of cases. Thus, providing older patients with personalized risk estimates for both dementia, including Alzheimer’s disease, and ASCVD could facilitate a comprehensive, evidence-based and patient-centered approach to therapeutic decision making in older adults. Unfortunately, current risk models were derived in younger adults, and fail to accurately predict risk in older adults. Second it remains unclear whether existing ASCVD risk models can also predict dementia risk and vice versa. Finally, to date, no one has evaluated whether these risk estimates help stratify therapeutic benefits of intervention in older adults. Leveraging a mentorship team of world experts in geriatrics, cardiology, and epidemiology, I will utilize data from subjects ≥75 years old from the National Heart, Lung, and Blood Institute (NHLBI) Pooled Cohorts in order to develop a clinical risk model to estimate risk of dementia, including Alzheimer’s disease, at 5 years from the selected baseline visit (Aim 1). In parallel, we will develop a clinical risk model to estimate the risk of ASCVD over the same time period in the same population of individuals ≥75 years old. In addition to traditional risk factors, we will derive these models using a novel set of candidate predictors not previously included in prior risk models including baseline cognition, functional status, depression, and mobility. Both models will then be externally validated using data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort (Aim 2). Finally, we will apply our model to patients ≥75 years old from the Systolic Blood Pressure Intervention Trial (SPRINT) in order to determine whether therapeutic benefit from intensive vs. conservative anti-hypertensive therapy in older adults differs across levels of predicted risk (Aim 3). Once developed and validated, we will develop an electronic health record-based version of the model for widespread dissemination and use in clinical care. The training I will receive through this work will give me expertise in model building and deployment and broaden my research interest in dementia including Alzheimer’s disease. It will also lay the groundwork for a future application for the Paul B. Beeson Emerging Leaders Career Development Award and other independent funding, with the ultimate goal of becoming an independent clinician-researcher focused on the care of older adults.
回应早期医学/外科专家向老化研究(GEMSSTAR)竞争的赠款 标题:生成新颖的新型预测模型,以估计老年人未来ASCVD和痴呆症的风险 项目摘要/摘要: 一个人的基准风险决定了许多众多众多的范围。 )疾病和痴呆症也增加了ASCVD的风险。对阿尔茨海默氏病的痴呆症估计以及ASCVD都可以促进以循证为中心的以患者为中心的治疗方法来制定老年人的治疗方法。反之亦然。临床风险模型估计痴呆症的风险,包括从选定的基线访问开始5年(AIM 1),我们将开发一个临床风险模型,以估计同一个人≥75Yeaars的同一时期。除了风险外,使用Anovel设置的模型candidididididididididididors在先前的风险模型中没有预测,包括基线认知,功能状态和移动性。为了确定与保存的密集型疗法的≥75例,从系统血液中差的Yeaars(SPRINT)中的模型。我们将开发基于ANN的健康记录,以供广泛的典型宣传,并在临床护理中使用。成为一名专注于老年人照顾的独立临床医生的奖项和其他独立资金目标。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Obesity and Undernutrition in Acute Myocardial Infarction.
急性心肌梗死中的肥胖和营养不良。
  • DOI:
    10.1016/j.amjcard.2023.07.111
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mangalesh,Sridhar;Nanna,MichaelG
  • 通讯作者:
    Nanna,MichaelG
An age-old dilemma: Defining the optimal revascularization approach in older adults.
Readmission and In-Hospital Outcomes After Transcatheter Aortic Valve Replacement in Patients With Dementia.
痴呆症患者经导管主动脉瓣置换术后的再入院和院内结果。
Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial.
单纯性收缩期高血压和单纯性舒张期高血压的抗高血压药物选择:ALLHAT 试验的二次分析。
  • DOI:
    10.1016/j.ahj.2022.07.006
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Wang,StephenY;Hanna,JonathanM;Gongal,Prajesh;Onuma,OyereK;Nanna,MichaelG
  • 通讯作者:
    Nanna,MichaelG
Moving the Field Forward: Untangling the Impact of Frailty on Patients With Advanced Heart Failure and on Prognosticating Outcomes.
  • DOI:
    10.1016/j.cardfail.2021.12.006
  • 发表时间:
    2022-05
  • 期刊:
  • 影响因子:
    6
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Nanna其他文献

Michael Nanna的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Nanna', 18)}}的其他基金

Generating novel predictive models to estimate the risk of future ASCVD & Dementia in older adults
生成新的预测模型来估计未来 ASCVD 的风险
  • 批准号:
    10302672
  • 财政年份:
    2021
  • 资助金额:
    $ 16.75万
  • 项目类别:

相似国自然基金

基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    53 万元
  • 项目类别:
    面上项目
基于miRNA介导ceRNA网络调控作用的防治阿尔茨海默病及认知障碍相关疾病药物的发现研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
LMTK1调控核内体转运介导阿尔茨海默病神经元Reserve机制研究
  • 批准号:
    81903703
  • 批准年份:
    2019
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
基于自组装多肽纳米探针检测蛋白标志物用于阿尔茨海默病精准诊断的研究
  • 批准号:
    31900984
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
  • 批准号:
    81901072
  • 批准年份:
    2019
  • 资助金额:
    20.5 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
  • 批准号:
    10676358
  • 财政年份:
    2024
  • 资助金额:
    $ 16.75万
  • 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 16.75万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 16.75万
  • 项目类别:
Individual Predoctoral Fellowship
个人博士前奖学金
  • 批准号:
    10752036
  • 财政年份:
    2024
  • 资助金额:
    $ 16.75万
  • 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 16.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了